SV1999000067A - Proteina humana c polipeptida ref. x-12279 - Google Patents

Proteina humana c polipeptida ref. x-12279

Info

Publication number
SV1999000067A
SV1999000067A SV1999000067A SV1999000067A SV1999000067A SV 1999000067 A SV1999000067 A SV 1999000067A SV 1999000067 A SV1999000067 A SV 1999000067A SV 1999000067 A SV1999000067 A SV 1999000067A SV 1999000067 A SV1999000067 A SV 1999000067A
Authority
SV
El Salvador
Prior art keywords
polypeptide
human protein
ref
human
protein
Prior art date
Application number
SV1999000067A
Other languages
English (en)
Inventor
Lihua Huang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV1999000067A publication Critical patent/SV1999000067A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE ENCUENTRA EN EL CAMPO DE LA MEDICINA HUMANA. MAS ESPECIFICAMENTE,EL INVENTO SE REFIERE A UNA PROTEINA HUMANA C POLIPEPTIDA QUE TIENE UNA CADENA LARGA TRUNCADA, A METODOS PARA UTILIZAR ESTA PROTEINA HUMANA C POLIPEPTIDA Y A COMPOSICIONES FARMACEUTICAS DE ESTA PROTEINA HUMANA POLIPEPTIDA.
SV1999000067A 1998-06-01 1999-05-28 Proteina humana c polipeptida ref. x-12279 SV1999000067A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8758598P 1998-06-01 1998-06-01

Publications (1)

Publication Number Publication Date
SV1999000067A true SV1999000067A (es) 2000-07-06

Family

ID=22206075

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1999000067A SV1999000067A (es) 1998-06-01 1999-05-28 Proteina humana c polipeptida ref. x-12279

Country Status (25)

Country Link
US (1) US20040038288A1 (es)
EP (1) EP1084235A4 (es)
JP (1) JP2002517191A (es)
KR (1) KR20010043941A (es)
CN (1) CN1303428A (es)
AR (1) AR020082A1 (es)
AU (1) AU4409399A (es)
BR (1) BR9910858A (es)
CA (1) CA2330171A1 (es)
CO (1) CO5070672A1 (es)
DZ (1) DZ2803A1 (es)
EA (1) EA200001254A1 (es)
HR (1) HRP20000826A2 (es)
HU (1) HUP0102014A3 (es)
ID (1) ID27282A (es)
IL (1) IL139595A0 (es)
NO (1) NO20006091L (es)
NZ (1) NZ507982A (es)
PE (1) PE20000561A1 (es)
PL (1) PL344349A1 (es)
SK (1) SK17502000A3 (es)
SV (1) SV1999000067A (es)
TR (1) TR200003552T2 (es)
WO (1) WO1999063070A1 (es)
ZA (1) ZA200006647B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025995A2 (en) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions and methods using md-2 mutants and chimeric proteins
CN108159399B (zh) * 2017-12-29 2020-07-24 华中科技大学同济医学院附属同济医院 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
ATE163048T1 (de) * 1989-12-29 1998-02-15 Zymogenetics Inc Hybrides protein c
WO1991012320A1 (en) * 1990-02-09 1991-08-22 Zymogenetics, Inc. Activated protein c with truncated light chain
JPH0564588A (ja) * 1991-08-14 1993-03-19 Teijin Ltd 短い重鎖を有するヒトプロテインｃおよび活性化ヒトプロテインｃ

Also Published As

Publication number Publication date
WO1999063070A1 (en) 1999-12-09
EA200001254A1 (ru) 2001-06-25
NO20006091D0 (no) 2000-11-30
HUP0102014A2 (hu) 2001-10-28
EP1084235A1 (en) 2001-03-21
US20040038288A1 (en) 2004-02-26
AR020082A1 (es) 2002-04-10
PE20000561A1 (es) 2000-07-22
BR9910858A (pt) 2001-03-06
ZA200006647B (en) 2001-11-15
EP1084235A4 (en) 2002-03-27
NZ507982A (en) 2004-01-30
DZ2803A1 (fr) 2003-12-01
SK17502000A3 (sk) 2001-09-11
CN1303428A (zh) 2001-07-11
PL344349A1 (en) 2001-11-05
NO20006091L (no) 2001-01-31
CA2330171A1 (en) 1999-12-09
AU4409399A (en) 1999-12-20
CO5070672A1 (es) 2001-08-28
ID27282A (id) 2001-03-22
HUP0102014A3 (en) 2003-09-29
HRP20000826A2 (en) 2001-10-31
TR200003552T2 (tr) 2001-05-21
KR20010043941A (ko) 2001-05-25
IL139595A0 (en) 2002-02-10
JP2002517191A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
SV2006002174A (es) Composicion de anticuerpo her2
CY1118038T1 (el) Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος
CR7875A (es) Variantes de inmunoglobina y usos de esto
CY1116055T1 (el) Σκευασματα υδροξυματαιρεσινολης για τοπικη εφαρμογη
ECSP088962A (es) Nuevos herbicidas
CO5160384A1 (es) Anticuerpo humanizado especifico para 4-1bb humano y composicion farmaceutica que comprende el mismo
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
ES2181873T3 (es) Fracciones de polifenoles del te, uso de las mismas y formulaciones que las contienen.
CY1110271T1 (el) Υδατικες παρατεταμενης-απελευθερωσης φαρμακοτεχνικες μορφες πρωτεϊνων
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
GT199900061A (es) Formulaciones farmaceuticas.
SV1997000079A (es) Dihidrato d de olancepina ref. x- 11062t
NO20062508L (no) Administrering av levodopa og karbidopa
CL2008000910A1 (es) Proteina de fusion que comprende una proteina que corta el peptido beta amiloide; composicion farmaceutica que la comprende, y su uso para prevenir y/o tratar enfermedades relacionadas con el peptido beta amiloide.
NO20054440L (no) Flytende formuleringer av tumornekrosefaktorbindende proteiner
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
AR003984A1 (es) Composiciones antipruriticas, cosmeticas y/o farmaceuticas, procedimiento para su preparacion y empleo de dichas composiciones para la obtencion de unmedicamento.
GT200200200A (es) Productos para la axila, con componente de bloqueo de agua
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
PT1354873E (pt) Sal de perindopril e as composicoes farmaceuticas que o contem
GT200300250A (es) Conjugados de hormona de crecimiento humana pegilados n-terminales y proceso para su preparacion
NO20034139D0 (no) Faste oralt-dispersible farmasöytiske formuleringer
DK1330258T3 (da) Kahalalid F-formulering
PA8469101A1 (es) Ligandos azabiciclicos de receptores 5ht1

Legal Events

Date Code Title Description
FD Lapse